Original article

Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c

BSE August-Jörg, R Hermann, M Weitz, E Renner

DOI: https://doi.org/10.4414/smw.2003.10300
Publication Date: 23.08.2003
Swiss Med Wkly. 2003;133(33-34):455-460

This text is only available as PDF .

Verpassen Sie keinen Artikel!

close